Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
888
-
Total 13F shares, excl. options
-
89.8M
-
Shares change
-
-1.01M
-
Total reported value, excl. options
-
$50.3B
-
Value change
-
-$627M
-
Put/Call ratio
-
1.04
-
Number of buys
-
450
-
Number of sells
-
-422
-
Price
-
$559.78
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2020
1,064 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2020.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 888 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.8M shares
of 105M outstanding shares and own 85.55% of the company stock.
Largest 10 shareholders include FMR LLC (12.7M shares), BlackRock Inc. (9.79M shares), VANGUARD GROUP INC (7.99M shares), Capital World Investors (6.64M shares), STATE STREET CORP (4.66M shares), WELLINGTON MANAGEMENT GROUP LLP (3.48M shares), LOOMIS SAYLES & CO L P (3.18M shares), POLEN CAPITAL MANAGEMENT LLC (1.94M shares), JPMORGAN CHASE & CO (1.92M shares), and Nuveen Asset Management, LLC (1.63M shares).
This table shows the top 888 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.